Trial Profile
A Study to Evaluate the Effectiveness of Mycophenolate Mofetil in Patients With Scleroderma-Associated Interstitial Lung Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jun 2016
Price :
$35
*
At a glance
- Drugs Mycophenolate mofetil (Primary)
- Indications Interstitial lung diseases
- Focus Therapeutic Use
- 27 Jun 2016 New trial record
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society